Media Summary: Navigating market uncertainty while making solid progress with our Data Quality initiative During the third quarter, we continued to ... Dr Hans Prenen presents the data from the January 2023 OPTIMIZE-1 BCRC continues to operate within a 10-year plan in an effort to manage multi-year research funding contracts (3 to 10 years in ...

Alligator Bioscience Q3 2025 Interim Report Call - Detailed Analysis & Overview

Navigating market uncertainty while making solid progress with our Data Quality initiative During the third quarter, we continued to ... Dr Hans Prenen presents the data from the January 2023 OPTIMIZE-1 BCRC continues to operate within a 10-year plan in an effort to manage multi-year research funding contracts (3 to 10 years in ... In this video, Rebecca Ahrens-Nicklas, MD, PhD, talks about successfully treating a patient for the first time with a personalized ... BioStock was a proud media partner to Swiss Nordic Bio

Photo Gallery

Alligator Bioscience Q3 2025 interim report call
Alligator Bioscience 2025 year end report call
Alligator Bioscience Q3 2024 Earnings Call
Alligator Bioscience 2026 Q1 interim report call
BioStock | Alligator Bioscience presents interim data | December 2022
Alligator Bioscience Q1 2023 report call
2022 AGM Alligator Bioscience - CEO Statement
ContextVision AB: Q3 interim report 2025
INVESTOR and ANALYST CALL for the Q3 2025 Financial Report
OPTIMIZE-1 presentation (Interim Futility Readout data from January 2023)
Alligator: "We're standing out very clearly"
2023 AGM Alligator Bioscience - CEO Statement
Sponsored
Sponsored
View Detailed Profile
Alligator Bioscience Q3 2025 interim report call

Alligator Bioscience Q3 2025 interim report call

On 23 October

Alligator Bioscience 2025 year end report call

Alligator Bioscience 2025 year end report call

On12 February 2026,

Sponsored
Alligator Bioscience Q3 2024 Earnings Call

Alligator Bioscience Q3 2024 Earnings Call

On October 24, 2024,

Alligator Bioscience 2026 Q1 interim report call

Alligator Bioscience 2026 Q1 interim report call

On 5 May 2026,

BioStock | Alligator Bioscience presents interim data | December 2022

BioStock | Alligator Bioscience presents interim data | December 2022

Alligator Bioscience's

Sponsored
Alligator Bioscience Q1 2023 report call

Alligator Bioscience Q1 2023 report call

Alligator Bioscience

2022 AGM Alligator Bioscience - CEO Statement

2022 AGM Alligator Bioscience - CEO Statement

Before the 2022

ContextVision AB: Q3 interim report 2025

ContextVision AB: Q3 interim report 2025

Navigating market uncertainty while making solid progress with our Data Quality initiative During the third quarter, we continued to ...

INVESTOR and ANALYST CALL for the Q3 2025 Financial Report

INVESTOR and ANALYST CALL for the Q3 2025 Financial Report

INVESTOR and ANALYST

OPTIMIZE-1 presentation (Interim Futility Readout data from January 2023)

OPTIMIZE-1 presentation (Interim Futility Readout data from January 2023)

Dr Hans Prenen presents the data from the January 2023 OPTIMIZE-1

Alligator: "We're standing out very clearly"

Alligator: "We're standing out very clearly"

Alligator Bioscience

2023 AGM Alligator Bioscience - CEO Statement

2023 AGM Alligator Bioscience - CEO Statement

Ahead of the 2023

KEYMED BIO-B 2025 annual report

KEYMED BIO-B 2025 annual report

Video update on KEYMED BIO-B

2020 Annual Report from Executive Director, Andrea Brocklebank

2020 Annual Report from Executive Director, Andrea Brocklebank

BCRC continues to operate within a 10-year plan in an effort to manage multi-year research funding contracts (3 to 10 years in ...

2025 Biodiversity Credits Webinar 3 of 4: Practical considerations that inform biodiversity markets

2025 Biodiversity Credits Webinar 3 of 4: Practical considerations that inform biodiversity markets

This webinar was part of the April

Annual Report: CHOP Scientists' 2025 Highlights with Rebecca Ahrens-Nicklas, MD, PhD

Annual Report: CHOP Scientists' 2025 Highlights with Rebecca Ahrens-Nicklas, MD, PhD

In this video, Rebecca Ahrens-Nicklas, MD, PhD, talks about successfully treating a patient for the first time with a personalized ...

BioStock Investor Pitch | Alligator Bioscience

BioStock Investor Pitch | Alligator Bioscience

Alligator Bioscience's

Alligator Biosciences | Swiss Nordic Bio 2025 | Interview

Alligator Biosciences | Swiss Nordic Bio 2025 | Interview

BioStock was a proud media partner to Swiss Nordic Bio

Compliance Under Transformation: Life Sciences and AI at the Crossroads | Operations Calling 2025

Compliance Under Transformation: Life Sciences and AI at the Crossroads | Operations Calling 2025

Learn more about Operations